Is losartan an ace inhibitor
Pro Research Analysisby
Searched over 200M research papers
Is Losartan an ACE Inhibitor?
Introduction to Losartan and ACE Inhibitors
Losartan is a medication commonly used to treat high blood pressure and heart failure. It is often confused with ACE inhibitors due to its role in the renin-angiotensin system (RAS). However, losartan is not an ACE inhibitor; it is an angiotensin II receptor blocker (ARB) .
Mechanism of Action: Losartan vs. ACE Inhibitors
Losartan: Angiotensin II Receptor Blocker (ARB)
Losartan works by selectively blocking the angiotensin II type 1 (AT1) receptors. This prevents angiotensin II from binding to these receptors, thereby inhibiting its vasoconstrictive and aldosterone-secreting effects, which helps lower blood pressure . Unlike ACE inhibitors, losartan does not inhibit the enzyme that converts angiotensin I to angiotensin II .
ACE Inhibitors: Enzyme Inhibition
ACE inhibitors, on the other hand, work by inhibiting the angiotensin-converting enzyme (ACE), which is responsible for converting angiotensin I to angiotensin II. This reduction in angiotensin II levels leads to decreased vasoconstriction and aldosterone secretion, thereby lowering blood pressure .
Comparative Efficacy and Safety
Blood Pressure and Renal Effects
Both losartan and ACE inhibitors are effective in reducing blood pressure and proteinuria, a common issue in patients with diabetic nephropathy and hypertension . Studies have shown that losartan and ACE inhibitors like enalapril have similar effects on reducing albuminuria and mean arterial blood pressure (MABP) . However, losartan does not cause the bradykinin accumulation associated with ACE inhibitors, which can lead to side effects such as cough .
Heart Failure and Post-Myocardial Infarction
In patients with heart failure, combining losartan with an ACE inhibitor did not show significant improvements in exercise capacity or quality of life compared to ACE inhibitor therapy alone. Additionally, in high-risk patients post-myocardial infarction, losartan was not superior to the ACE inhibitor captopril in reducing all-cause mortality, although it was better tolerated.
Conclusion
Losartan is not an ACE inhibitor; it is an angiotensin II receptor blocker (ARB). While both losartan and ACE inhibitors are effective in managing hypertension and related conditions, they operate through different mechanisms within the renin-angiotensin system. Losartan blocks the effects of angiotensin II at the receptor level, whereas ACE inhibitors prevent the formation of angiotensin II. Understanding these differences is crucial for optimizing treatment strategies for hypertension and heart failure.
Sources and full results
Most relevant research papers on this topic